This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Wyeth, Wyeth Holdings Corporation. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Mark William Cutler: Innovator in Viral Purification Processes
Introduction
Mark William Cutler is a notable inventor based in Bloomingdale, NJ (US). He has made significant contributions to the field of virology, particularly in the purification processes of viruses. With a total of 2 patents, Cutler's work has implications for both research and therapeutic applications.
Latest Patents
Cutler's latest patents include innovative processes for isolating purified vesicular stomatitis virus (VSV) from cell culture. This process involves several steps, including clarifying cell culture fluid, filtering, and purifying the VSV using tangential flow filtration. His second patent focuses on increasing respiratory syncytial virus (RSV) surface glycoprotein yields using a mutant strain of RSV. This method results in a significant increase in the production of glycoproteins, which can be formulated for immunogenic compositions to protect against RSV-related diseases.
Career Highlights
Throughout his career, Cutler has worked with prominent companies such as Wyeth and Wyeth Holdings Corporation. His experience in these organizations has allowed him to develop and refine his innovative techniques in viral purification.
Collaborations
Cutler has collaborated with notable colleagues, including Mirelli Fino and Robert Repetto. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Mark William Cutler's contributions to viral purification processes highlight his innovative spirit and dedication to advancing virology. His patents not only enhance our understanding of virus isolation but also pave the way for potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
